Nuclear medicine doses and delivery service to mike O'callaghan medical center - nellis AFB, NV
Active Purchase Order Awarded Last action
- Contract number
- HT941025P0083
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $450,000
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Mammography Reporting Services (MRS), U. S. Naval Hospital Yokosuka, Japan Pre-Solicitation · HT941025N0058 · Posted Mar 19, 2025
- Contract value 40% obligated
-
- $450,000.00 Current, with exercised options
- $1,125,000.00 Potential, with all options
- Completion date 32% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Nellis AFB, NV, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $225,000 | |
| Other Administrative Action | $0 | |
| Original award | $225,000 |
About this award
The Defense Health Agency issued a purchase order to Cardinal Health 414, LLC for nuclear medicine doses and delivery service valued at $1,125,000 as of April 1, 2025. Work is performed at Nellis Air Force Base, Nevada. The order covers nuclear medicine diagnostic imaging study materials and radiopharmaceutical delivery to Mike O'Callaghan Medical Center under a firm fixed-price structure with an ultimate completion date of March 31, 2030. Cardinal Health 414 specializes in manufacturing, testing, and distributing radiopharmaceuticals and medical isotopes, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose, and gallium-67, along with specialized therapeutic products such as Xofigo and Lymphoseek. The company holds NRC licensing and FDA approval for radiopharmaceutical products and maintains DOT compliance for radioactive materials transport.
Quick answers
Who was awarded contract HT941025P0083?
HT941025P0083 was awarded to Cardinal Health 414, LLC by Defense Health Agency (Department of Defense) on April 1, 2025.
How much is contract HT941025P0083 worth?
The government has obligated $450,000 on HT941025P0083. Its potential value, with all options, is $1,125,000.
Was contract HT941025P0083 competed?
The extent of competition for HT941025P0083 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award